Perimenopause represents a neuro‑hormonal transition rather than a simple decline in oestrogen. Fluctuating oestrogen and progesterone influence sleep, stress resilience, glucose metabolism, bone turnover, mood regulation and muscle recovery.
Magnesium sits at the centre of these systems.
Magnesium is a cofactor in more than 300 enzymatic reactions, including ATP production, neurotransmitter regulation, insulin signaling, and vitamin D activation. During perimenopause, physiological changes can increase magnesium demand.
1. Hormonal Fluctuations
Oestrogen influences magnesium distribution and retention. As oestrogen levels fluctuate unpredictably in perimenopause, magnesium balance may become less stable.
2. Nervous System Regulation
Magnesium modulates NMDA receptors and supports GABAergic activity. Declining progesterone combined with chronic stress can increase sympathetic activation, potentially increasing magnesium utilisation.
3. Sleep Architecture Changes
Magnesium contributes to melatonin production and neuromuscular relaxation. Sleep disruption, common in perimenopause, increases stress hormone output, which can further deplete magnesium.
4. Insulin Resistance and Metabolic Shifts
Insulin sensitivity often declines during perimenopause. Magnesium is essential for insulin receptor activity and glucose transport into cells. Higher metabolic stress may increase magnesium requirements.
5. Bone Turnover
Oestrogen decline accelerates bone remodelling. Magnesium regulates calcium transport, parathyroid hormone function and vitamin D activation, making adequate intake critical for skeletal health.
6. Chronic Stress and Cortisol
Psychological and physiological stress increase urinary magnesium excretion. Midlife stress load may therefore contribute to suboptimal magnesium status.
Potential Signs of Suboptimal Magnesium Status:
⛔️ Muscle cramps or tightness
⛔️ Poor sleep
⛔️ Anxiety or irritability
⛔️ Headaches
⛔️ Sugar cravings
⛔️ Constipation
⛔️ Palpitations
For a convenient, high-quality option, try Doctor Verena’s Magnesium Glycinate, available in 60 capsules or 120 capsules, making it easy to support your daily magnesium needs.
While the Recommended Dietary Intake (RDI) for adult women is approximately 310–320 mg/day, some clinicians observe that symptomatic perimenopausal women may benefit from total intakes in the range of 350–500 mg/day (diet plus supplementation), depending on individual assessment.
Common supplemental forms:
✔️ Magnesium glycinate – calming and well tolerated
✔️ Magnesium threonate – cognitive support
✔️ Magnesium citrate – bowel motility support
✔️ Magnesium malate – fatigue and muscle pain support
As always, supplementation should be individualised, particularly in the presence of renal impairment or medication use.
References
Rosanoff, A., Weaver, C. M., & Rude, R. K. (2012). Suboptimal magnesium status in the United States: are the health consequences underestimated? Nutrition Reviews, 70(3), 153–164.
Barbagallo, M., & Dominguez, L. J. (2010). Magnesium and type 2 diabetes. World Journal of Diabetes, 1(3), 115–119.
Volpe, S. L. (2013). Magnesium in disease prevention and overall health. Advances in Nutrition, 4(3), 378S–383S.
Castiglioni, S., Cazzaniga, A., Albisetti, W., & Maier, J. A. (2013). Magnesium and osteoporosis: current state of knowledge and future research directions. Nutrients, 5(8), 3022–3033.
Eby, G. A., & Eby, K. L. (2006). Rapid recovery from major depression using magnesium treatment. Medical Hypotheses, 67(2), 362–370.
Institute of Medicine. (1997). Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. National Academies Press.